Loading…
Superficial pT1G3 bladder tumor: 24 case reports
The authors report 24 patients presenting a transitional tumor of bladder pT1G3 collected between January 1996 and December 2000. They represent 19% of the superficial tumors of bladder. Two patients had of straightaway a cystectomy after resection for an unverifiable tumor by endoscopy and another...
Saved in:
| Published in: | Annales d'urologie 2003-08, Vol.37 (4), p.199-202 |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Article |
| Language: | fre |
| Subjects: | |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | |
|---|---|
| cites | |
| container_end_page | 202 |
| container_issue | 4 |
| container_start_page | 199 |
| container_title | Annales d'urologie |
| container_volume | 37 |
| creator | Benchekroun, A el Alj, H A el Sayegh, H Lachkar, A Nouini, Y Benslimane, L Belahnech, Z Faik, M |
| description | The authors report 24 patients presenting a transitional tumor of bladder pT1G3 collected between January 1996 and December 2000. They represent 19% of the superficial tumors of bladder. Two patients had of straightaway a cystectomy after resection for an unverifiable tumor by endoscopy and another after a second resection discovering a real pT2. Only 5 patients received a BCG therapy is 24% of the cases. A recurrence without progression has been noted in 38% of the cases and a progression in 19% of the patients. These last patients had a cystectomy and with a follow-up to 28 months, no recurrence has been noted. |
| format | article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_73624344</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73624344</sourcerecordid><originalsourceid>FETCH-LOGICAL-p543-a7f91836fdd5d567905f0ac726f656a4835c7d0c002800122eb966bbe075917b3</originalsourceid><addsrcrecordid>eNo1j71OwzAYRT2AaCm8AvLEFunzf8yGKiiVKjGQPfLPZykoIcZOBt6eSpTpLEdH916RLQCIRkpgG3Jb6ycA05bJG7Jh3CpmmNgS-FgzljSEwY00d-wgqB9djFjosk5zeaJc0uAq0oJ5Lku9I9fJjRXvL9yR7vWl2781p_fDcf98arKSonEmWdYKnWJUUWljQSVwwXCdtNJOtkIFEyEA8PY8i3P0VmvvEYyyzHixI49_2Vzm7xXr0k9DDTiO7gvntfZGaC6FlGfx4SKufsLY5zJMrvz0_xfFLwN6SRU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73624344</pqid></control><display><type>article</type><title>Superficial pT1G3 bladder tumor: 24 case reports</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Benchekroun, A ; el Alj, H A ; el Sayegh, H ; Lachkar, A ; Nouini, Y ; Benslimane, L ; Belahnech, Z ; Faik, M</creator><creatorcontrib>Benchekroun, A ; el Alj, H A ; el Sayegh, H ; Lachkar, A ; Nouini, Y ; Benslimane, L ; Belahnech, Z ; Faik, M</creatorcontrib><description>The authors report 24 patients presenting a transitional tumor of bladder pT1G3 collected between January 1996 and December 2000. They represent 19% of the superficial tumors of bladder. Two patients had of straightaway a cystectomy after resection for an unverifiable tumor by endoscopy and another after a second resection discovering a real pT2. Only 5 patients received a BCG therapy is 24% of the cases. A recurrence without progression has been noted in 38% of the cases and a progression in 19% of the patients. These last patients had a cystectomy and with a follow-up to 28 months, no recurrence has been noted.</description><identifier>ISSN: 0003-4401</identifier><identifier>PMID: 12951713</identifier><language>fre</language><publisher>France</publisher><subject>Adult ; Aged ; Aged, 80 and over ; BCG Vaccine - therapeutic use ; Cystectomy ; Disease Progression ; Female ; Humans ; Male ; Middle Aged ; Neoplasm Staging ; Treatment Outcome ; Urinary Bladder Neoplasms - drug therapy ; Urinary Bladder Neoplasms - pathology ; Urinary Bladder Neoplasms - surgery</subject><ispartof>Annales d'urologie, 2003-08, Vol.37 (4), p.199-202</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12951713$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Benchekroun, A</creatorcontrib><creatorcontrib>el Alj, H A</creatorcontrib><creatorcontrib>el Sayegh, H</creatorcontrib><creatorcontrib>Lachkar, A</creatorcontrib><creatorcontrib>Nouini, Y</creatorcontrib><creatorcontrib>Benslimane, L</creatorcontrib><creatorcontrib>Belahnech, Z</creatorcontrib><creatorcontrib>Faik, M</creatorcontrib><title>Superficial pT1G3 bladder tumor: 24 case reports</title><title>Annales d'urologie</title><addtitle>Ann Urol (Paris)</addtitle><description>The authors report 24 patients presenting a transitional tumor of bladder pT1G3 collected between January 1996 and December 2000. They represent 19% of the superficial tumors of bladder. Two patients had of straightaway a cystectomy after resection for an unverifiable tumor by endoscopy and another after a second resection discovering a real pT2. Only 5 patients received a BCG therapy is 24% of the cases. A recurrence without progression has been noted in 38% of the cases and a progression in 19% of the patients. These last patients had a cystectomy and with a follow-up to 28 months, no recurrence has been noted.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>BCG Vaccine - therapeutic use</subject><subject>Cystectomy</subject><subject>Disease Progression</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neoplasm Staging</subject><subject>Treatment Outcome</subject><subject>Urinary Bladder Neoplasms - drug therapy</subject><subject>Urinary Bladder Neoplasms - pathology</subject><subject>Urinary Bladder Neoplasms - surgery</subject><issn>0003-4401</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><recordid>eNo1j71OwzAYRT2AaCm8AvLEFunzf8yGKiiVKjGQPfLPZykoIcZOBt6eSpTpLEdH916RLQCIRkpgG3Jb6ycA05bJG7Jh3CpmmNgS-FgzljSEwY00d-wgqB9djFjosk5zeaJc0uAq0oJ5Lku9I9fJjRXvL9yR7vWl2781p_fDcf98arKSonEmWdYKnWJUUWljQSVwwXCdtNJOtkIFEyEA8PY8i3P0VmvvEYyyzHixI49_2Vzm7xXr0k9DDTiO7gvntfZGaC6FlGfx4SKufsLY5zJMrvz0_xfFLwN6SRU</recordid><startdate>200308</startdate><enddate>200308</enddate><creator>Benchekroun, A</creator><creator>el Alj, H A</creator><creator>el Sayegh, H</creator><creator>Lachkar, A</creator><creator>Nouini, Y</creator><creator>Benslimane, L</creator><creator>Belahnech, Z</creator><creator>Faik, M</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>200308</creationdate><title>Superficial pT1G3 bladder tumor: 24 case reports</title><author>Benchekroun, A ; el Alj, H A ; el Sayegh, H ; Lachkar, A ; Nouini, Y ; Benslimane, L ; Belahnech, Z ; Faik, M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p543-a7f91836fdd5d567905f0ac726f656a4835c7d0c002800122eb966bbe075917b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>fre</language><creationdate>2003</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>BCG Vaccine - therapeutic use</topic><topic>Cystectomy</topic><topic>Disease Progression</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neoplasm Staging</topic><topic>Treatment Outcome</topic><topic>Urinary Bladder Neoplasms - drug therapy</topic><topic>Urinary Bladder Neoplasms - pathology</topic><topic>Urinary Bladder Neoplasms - surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Benchekroun, A</creatorcontrib><creatorcontrib>el Alj, H A</creatorcontrib><creatorcontrib>el Sayegh, H</creatorcontrib><creatorcontrib>Lachkar, A</creatorcontrib><creatorcontrib>Nouini, Y</creatorcontrib><creatorcontrib>Benslimane, L</creatorcontrib><creatorcontrib>Belahnech, Z</creatorcontrib><creatorcontrib>Faik, M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Annales d'urologie</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Benchekroun, A</au><au>el Alj, H A</au><au>el Sayegh, H</au><au>Lachkar, A</au><au>Nouini, Y</au><au>Benslimane, L</au><au>Belahnech, Z</au><au>Faik, M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Superficial pT1G3 bladder tumor: 24 case reports</atitle><jtitle>Annales d'urologie</jtitle><addtitle>Ann Urol (Paris)</addtitle><date>2003-08</date><risdate>2003</risdate><volume>37</volume><issue>4</issue><spage>199</spage><epage>202</epage><pages>199-202</pages><issn>0003-4401</issn><abstract>The authors report 24 patients presenting a transitional tumor of bladder pT1G3 collected between January 1996 and December 2000. They represent 19% of the superficial tumors of bladder. Two patients had of straightaway a cystectomy after resection for an unverifiable tumor by endoscopy and another after a second resection discovering a real pT2. Only 5 patients received a BCG therapy is 24% of the cases. A recurrence without progression has been noted in 38% of the cases and a progression in 19% of the patients. These last patients had a cystectomy and with a follow-up to 28 months, no recurrence has been noted.</abstract><cop>France</cop><pmid>12951713</pmid><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0003-4401 |
| ispartof | Annales d'urologie, 2003-08, Vol.37 (4), p.199-202 |
| issn | 0003-4401 |
| language | fre |
| recordid | cdi_proquest_miscellaneous_73624344 |
| source | ScienceDirect Freedom Collection 2022-2024 |
| subjects | Adult Aged Aged, 80 and over BCG Vaccine - therapeutic use Cystectomy Disease Progression Female Humans Male Middle Aged Neoplasm Staging Treatment Outcome Urinary Bladder Neoplasms - drug therapy Urinary Bladder Neoplasms - pathology Urinary Bladder Neoplasms - surgery |
| title | Superficial pT1G3 bladder tumor: 24 case reports |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T19%3A16%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Superficial%20pT1G3%20bladder%20tumor:%2024%20case%20reports&rft.jtitle=Annales%20d'urologie&rft.au=Benchekroun,%20A&rft.date=2003-08&rft.volume=37&rft.issue=4&rft.spage=199&rft.epage=202&rft.pages=199-202&rft.issn=0003-4401&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E73624344%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p543-a7f91836fdd5d567905f0ac726f656a4835c7d0c002800122eb966bbe075917b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=73624344&rft_id=info:pmid/12951713&rfr_iscdi=true |